To determine whether RAD21 binding to regulatory elements could contribute to differences in MYC expression between breast cancer cell lines, we performed RAD21 ChIP on MCF7, T47D and MDA-MB-231 cells cultured in their respective complete media (Figure 5). The gene discussed is MYC; the disease is breast carcinoma.